Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being "extremely effective" or "effective." A pressing question for many users of GLP-1 receptor agonist ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

Results from a new study suggest a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could ...

The changes coming with the new year — including a lower cap on out-of-pocket prescription-drug costs and a new program designed to help enrollees spread out their medication costs over the ...

Medicare's prescription drug coverage will change in 2025. There will be a $2000 cap on out-of-pocket expenses for ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...